Quarterly report · Q2
9220.TEDINET S100SA5O
Period2023-04-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥5.1bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥9.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.8bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥401m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥339m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥429m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥737m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥351m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥427m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥350m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥300m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥445m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥204m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥300m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥204m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥9.1bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥9.0bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥8.7bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.8bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥6.0bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.3bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥3.0bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥2.8bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.4bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.4bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.2bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.4bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥555m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥970m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥475m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥169m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥849m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥278m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥364m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥464m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥597m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥112.11 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥56.08 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥167.39 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥77.42 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥40.13 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 36.2% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.7% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.7% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E37523-000Nursing Care Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥3.0bn |
| jpcrp040300-q2r_E37523-000Nursing Care Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥3.0bn |
| jpcrp040300-q2r_E37523-000Nursing Care Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥200m |
| jpcrp040300-q2r_E37523-000Nursing Care Equipment Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E37523-000Nursing Care Equipment Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E37523-000Nursing Care Equipment Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥201m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥5.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥5.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥401m |
| jpcrp040300-q2r_E37523-000Nursing Care Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥2.8bn |
| jpcrp040300-q2r_E37523-000Nursing Care Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥2.8bn |
| jpcrp040300-q2r_E37523-000Nursing Care Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥163m |
| jpcrp040300-q2r_E37523-000Nursing Care Equipment Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥2.0bn |
| jpcrp040300-q2r_E37523-000Nursing Care Equipment Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥2.0bn |
| jpcrp040300-q2r_E37523-000Nursing Care Equipment Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥176m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥4.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥4.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥339m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 450
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)かなで監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)水野 雅史 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)若月 健 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 4766468000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 5122993000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 9619401000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 350784000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 429429000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 737221000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 204404000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 300002000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 444930000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 206801000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 303684000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 450364000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 2828842000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 3287783000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 3037618000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 8655866000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 9088282000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 9019056000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 77.42 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 112.11 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 167.39 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.327 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.362 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.337 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 475090000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 554657000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 969838000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -277611000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -169487000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -849259000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | 596537000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | -364150000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 463714000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 2388610000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 2199845000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 2178822000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 40.13 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 56.08 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 2676000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 2676000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 2676000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 2676000 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |